No Data
No Data
Oruka Therapeutics Price Target Announced at $40.00/Share by Jefferies
Jefferies Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $40
Jefferies analyst Michael Yee maintains $Oruka Therapeutics(ORKA.US)$ with a buy rating, and maintains the target price at $40.According to TipRanks data, the analyst has a success rate of 42.8% and
Jefferies Initiates Oruka Therapeutics(ORKA.US) With Buy Rating, Announces Target Price $40
Jefferies analyst Michael Yee initiates coverage on $Oruka Therapeutics(ORKA.US)$ with a buy rating, and sets the target price at $40.According to TipRanks data, the analyst has a success rate of 42.8
Oruka Therapeutics Announces $200M Private Financing
Oruka Therapeutics Announced A Private Investment In Public Equity Financing For Gross Proceeds Of Approximately $200M, Offering 5.6M Shares At $23/Share, 2,439 Shares Of Its Series A Non-voting Convertible Preferred Stock At $23,000 Per Share, And...
Express News | Oruka Therapeutics Inc - Company Expects Cash to Fund Operations Through 2027
No Data
No Data